Skip to main content
Back to European Investment Bank

European Investment Bank's Life Science Portfolio

Browse 13 Life Science companies funded by European Investment Bank. See funding amounts, founder contacts, and investment details.

Life Science Companies
13
Total Funding in Life Science
$437.4M

Life Science Portfolio Companies (13)

Export
Emergency MedicineHealth CareLife ScienceMedical DevicePersonal Health

Protembis is a medical device start-up company with its R&D base in the engineering and technology.

Aachen, Germany
July 2024
$21.6M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical

Inbiose is a B2B biotech company that develops specialty carbohydrates.

Zwijnaarde, Belgium
July 2021
$17.7M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceTherapeutics

ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.

Zwijnaarde, Belgium
June 2023
$1.7M
Grant

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceTherapeutics

Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.

Amsterdam, The Netherlands
June 2026
$35.2M
Undisclosed

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMarket ResearchQuantum Computing

Algorithmiq develops algorithms to solve currently inaccessible problems in life sciences.

Turku, Finland
May 2026
$15.3M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife Science

DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition.

Barcelona, Spain
April 2025
$56.9M
Series C

Founder Contacts

30,000+ verified contacts

BiopharmaLife ScienceMedicalPharmaceutical

Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.

Dublin, Ireland
February 2022
$125.0M
Post-IPO Debt

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife ScienceMedicalOncologyPharmaceutical

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

Madrid, Spain
February 2025
$15.5M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiopharmaBiotechnologyHealth CareLife Science

Enterome is a clinical-stage company developing breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases.

Paris, France
June 2025
$19.0M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical Device

A innovative orthopaedic implant for the treatment of thumb base arthritis.

Galway, Ireland
July 2024
$14.0M
Series A

Founder Contacts

30,000+ verified contacts

BiotechnologyHealth CareLife ScienceMedicalWellness

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

Hellerup, Denmark
October 2023
$57.4M
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts

BiotechnologyFood and BeverageLife Science

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

Berlin, Germany
January 2025
$36.1M
Debt Financing

Founder Contacts

30,000+ verified contacts

BiotechnologyLife ScienceMedical DeviceOncology

LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.

Amsterdam, The Netherlands
October 2024
$21.9M
Debt Financing

Founder Contacts

30,000+ verified contacts

Explore European Investment Bank's Full Portfolio

View all companies funded by European Investment Bank across every industry and funding stage.

View Full European Investment Bank Portfolio